WASHINGTON— Alzheimer’s disease and dementia may be more common in women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), according to a review of existing evidence published in the Journal of the Endocrine Society.
PMOS affects 10% to 15% of women worldwide and is linked to a wide range of health issues, including diabetes, heart disease, stroke, depression, anxiety, infertility and endometrial cancer. The condition can have lifelong effects and may also affect males, but in different ways.
“Clinically, PMOS patients exhibit mild but reproducible impairments in executive function and memory, alongside structural and functional brain alterations, which could suggest greater risk for Alzheimer’s disease and dementia. Current evidence suggests that any association between PMOS and Alzheimer’s disease and dementia is likely mediated by metabolic comorbidities, particularly insulin resistance and obesity, rather than an independent effect of PMOS itself,” said study co-author Ricardo Azziz, M.D., M.P.H., M.B.A., of the University of Alabama at Birmingham in Birmingham, Ala.
The researchers conducted a comprehensive PubMed search, from inception through October 2025 and inferred people with PMOS may be at greater risk for changes in memory, thinking, brain health, and pathways linked to Alzheimer’s disease.
They also deduced that these risks may be related to common health conditions that often occur alongside PMOS, such as obesity and metabolic disorders. The review highlights important gaps in knowledge and identifies key areas for future research.
“Understanding how these two disorders that significantly impact women’s health worldwide are inter-related presents the opportunity to not only understand what these two very important morbidities have in common but also to discover new pathways and causes which could guide the development of novel treatments for these devastating diseases,” Azziz said.
Other authors are Mina Amiri of Tehran University of Medical Sciences in Tehran, Iran, and the Foundation for Research and Education Excellence in Vestavia, Ala.; Armita Kakavand Hamidi of Tehran University of Medical Sciences; Daniel L. Farkas of the Foundation for Research and Education Excellence and the University of Southern California in Los Angeles, Calif.; and Richard P. Buyalos of the Foundation for Research and Education Excellence and the University of Alabama at Birmingham.
The study was funded by the Foundation for Research and Education Excellence.
“Potential Links Between PCOS/PMOS and Alzheimer's Disease and Related Dementias” was published online.
# # #
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom .
Journal of the Endocrine Society